For Companies

What is the ATLAS Project?

The ATLAS Project is a multinational clinical trial network across nine Asian countries, led by the National Cancer Center Hospital, Japan.

Under Japan’s leadership, multiple international collaborative clinical trials are conducted in parallel, aiming to accelerate regulatory approval and practical implementation of pharmaceuticals and medical devices throughout Asia.

How Can It Be Used?

Conducting Investigator-Initiated Trials for Industry Products

Pharmaceutical and medical device companies can implement their development products as investigator-initiated clinical trials through the ATLAS network.

Clinical trials can include not only Asian sites, but also participating institutions in the United States, Europe, and other regions.

Utilizing MASTER KEY Asia as a Screening Platform for Industry Trials

MASTER KEY Asia can be used to screen patients based on biomarkers.
Patients who test positive can then be enrolled into company-sponsored clinical trials.

Leveraging the ATLAS Network for Industry-Sponsored Clinical Trials

The ATLAS network can be utilized for company-sponsored trials across Asia, including the implementation of decentralized clinical trials (DCTs).

Please refer to the slide materials below for more detailed information:
For Companies_Feb 23, 2025

Contact Information

ATLAS Project Team
Department of International Development
National Cancer Center Hospital, Japan

atlas-pr☆ml.res.ncc.go.jp  (Please replace ☆ with @)